BRCA1 promoter methylation in leukocytes

From Aaushi

Jump to navigation Jump to search

^[1]

Indications

assessment of ovarian cancer risk

Clinical significance

BRCA1 promoter methylation in leukocytes is positively associated with risk for high-grade serous ovarian cancer^[1]

More general terms

molecular diagnostic test

References

↑ ^1.0 ^1.1 Lonning PE, Berge EO, Bjornslett M et al White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk. Ann Intern Med. 2018 Jan 16. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29335712

Retrieved from "https://aaushi.info/w/index.php?title=A55078&oldid=952492"

↑ Back to top